Join the club for FREE to access the whole archive and other member benefits.

Maja Milanovic

Study Director in division of Oncology/Immunology at preclinics

I am an experienced cancer research scientist with background in exploring mechanisms of hematological diseases, immune reactions to tumors, stem cell biology, gene expression patterns, epigenetic reprogramming, cancer signaling and cellular stress responses. I have thorough scientific knowledge and hands-on experience in discovery and validation of novel cancer treatments, based on targeting signaling mediators, metabolic conditioning or immunomodulation. I am skilled in team leadership, project planning and coordination, as well as presentation of results and scientific strategies to different audiences.

My mission is to use the emerging knowledge to explore and design precision oncology approaches which tackle the current limitations of cancer therapies.

Visit website: https://mkfz.charite.de/en/metas/person_detail/person/address_detail/milanovic/

 maja-milanovic-67833b1

See also: Company preclinics - Drug development, drug delivery formulations and medical devices company

Details last updated 16-Apr-2020

Maja Milanovic News

Escape from senescence boosts tumour growth

Escape from senescence boosts tumour growth

Nature - 20-Dec-2017

Senescence is usually thought to be irreversible. Many anti-cancer therapies cause cancer-cell s...